Global Population Structure and Evolution of <named-content content-type="genus-species">Bordetella pertussis</named-content> and Their Relationship with Vaccination
Marieke J. Bart,
Simon R. Harris,
Abdolreza Advani,
Yoshichika Arakawa,
Daniela Bottero,
Valérie Bouchez,
Pamela K. Cassiday,
Chuen-Sheue Chiang,
Tine Dalby,
Norman K. Fry,
María Emilia Gaillard,
Marjolein van Gent,
Nicole Guiso,
Hans O. Hallander,
Eric T. Harvill,
Qiushui He,
Han G. J. van der Heide,
Kees Heuvelman,
Daniela F. Hozbor,
Kazunari Kamachi,
Gennady I. Karataev,
Ruiting Lan,
Anna Lutyńska,
Ram P. Maharjan,
Jussi Mertsola,
Tatsuo Miyamura,
Sophie Octavia,
Andrew Preston,
Michael A. Quail,
Vitali Sintchenko,
Paola Stefanelli,
M. Lucia Tondella,
Raymond S. W. Tsang,
Yinghua Xu,
Shu-Man Yao,
Shumin Zhang,
Julian Parkhill,
Frits R. Mooi
Affiliations
Marieke J. Bart
Centre for Infectious Diseases Research, Diagnostics and Screening (IDS), Centre for Infectious Diseases Control (CIb), National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Simon R. Harris
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom
Abdolreza Advani
Swedish Institute for Communicable Disease Control (SMI), Solna, Sweden
Yoshichika Arakawa
National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan
Daniela Bottero
Laboratorio VacSal, Instituto de Biotecnología y Biología Molecular, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CONICET, La Plata, Argentina
Valérie Bouchez
Institut Pasteur, Molecular Prevention and Therapy of Human Infections, Paris, France
Pamela K. Cassiday
National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
Chuen-Sheue Chiang
Centers for Disease Control, Taipei, Taiwan, Republic of China
Tine Dalby
Microbiology & Infection Control, Statens Serum Institut, Copenhagen, Denmark
Norman K. Fry
Public Health England—Respiratory and Vaccine Preventable Bacteria Reference Unit, Colindale, United Kingdom
María Emilia Gaillard
Laboratorio VacSal, Instituto de Biotecnología y Biología Molecular, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CONICET, La Plata, Argentina
Marjolein van Gent
Centre for Infectious Diseases Research, Diagnostics and Screening (IDS), Centre for Infectious Diseases Control (CIb), National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Nicole Guiso
Institut Pasteur, Molecular Prevention and Therapy of Human Infections, Paris, France
Hans O. Hallander
Swedish Institute for Communicable Disease Control (SMI), Solna, Sweden
Eric T. Harvill
Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, Pennsylvania, USA
Qiushui He
Department of Infectious Disease Surveillance and Control, National Institute for Health and Welfare, Finland
Han G. J. van der Heide
Centre for Infectious Diseases Research, Diagnostics and Screening (IDS), Centre for Infectious Diseases Control (CIb), National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Kees Heuvelman
Centre for Infectious Diseases Research, Diagnostics and Screening (IDS), Centre for Infectious Diseases Control (CIb), National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands
Daniela F. Hozbor
Laboratorio VacSal, Instituto de Biotecnología y Biología Molecular, Facultad de Ciencias Exactas, Universidad Nacional de La Plata, CONICET, La Plata, Argentina
Kazunari Kamachi
National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan
Gennady I. Karataev
Gamaleya Research Institute for Epidemiology and Microbiology, Ministry of Health Russian Federation, Moscow, Russian Federation
Ruiting Lan
School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia
Anna Lutyńska
National Institute of Public Health, National Institute of Hygiene, Warsaw, Poland
Ram P. Maharjan
School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia
Jussi Mertsola
Department of Pediatrics, Turku University Hospital, Turku, Finland
Tatsuo Miyamura
National Institute of Infectious Diseases, Shinjuku-ku, Tokyo, Japan
Sophie Octavia
School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, Australia
Andrew Preston
Department of Biology and Biochemistry, University of Bath, Bath, United Kingdom
Michael A. Quail
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom
Vitali Sintchenko
Centre for Infectious Diseases and Microbiology—Public Health, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, New South Wales, Australia
Paola Stefanelli
Department of Infectious, Parasitic & Immune-Mediated Diseases, Istituto Superiore di Sanita, Rome, Italy
M. Lucia Tondella
National Center for Immunization and Respiratory Diseases (NCIRD), Centers for Disease Control and Prevention (CDC), Atlanta, Georgia, USA
Raymond S. W. Tsang
Laboratory for Syphilis Diagnostics and Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada
Yinghua Xu
National Institute for Food and Drug Control, Beijing, Republic of China
Shu-Man Yao
Centers for Disease Control, Taipei, Taiwan, Republic of China
Shumin Zhang
National Institute for Food and Drug Control, Beijing, Republic of China
Julian Parkhill
Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom
Frits R. Mooi
Centre for Infectious Diseases Research, Diagnostics and Screening (IDS), Centre for Infectious Diseases Control (CIb), National Institute of Public Health and the Environment (RIVM), Bilthoven, The Netherlands
ABSTRACT Bordetella pertussis causes pertussis, a respiratory disease that is most severe for infants. Vaccination was introduced in the 1950s, and in recent years, a resurgence of disease was observed worldwide, with significant mortality in infants. Possible causes for this include the switch from whole-cell vaccines (WCVs) to less effective acellular vaccines (ACVs), waning immunity, and pathogen adaptation. Pathogen adaptation is suggested by antigenic divergence between vaccine strains and circulating strains and by the emergence of strains with increased pertussis toxin production. We applied comparative genomics to a worldwide collection of 343 B. pertussis strains isolated between 1920 and 2010. The global phylogeny showed two deep branches; the largest of these contained 98% of all strains, and its expansion correlated temporally with the first descriptions of pertussis outbreaks in Europe in the 16th century. We found little evidence of recent geographical clustering of the strains within this lineage, suggesting rapid strain flow between countries. We observed that changes in genes encoding proteins implicated in protective immunity that are included in ACVs occurred after the introduction of WCVs but before the switch to ACVs. Furthermore, our analyses consistently suggested that virulence-associated genes and genes coding for surface-exposed proteins were involved in adaptation. However, many of the putative adaptive loci identified have a physiological role, and further studies of these loci may reveal less obvious ways in which B. pertussis and the host interact. This work provides insight into ways in which pathogens may adapt to vaccination and suggests ways to improve pertussis vaccines. IMPORTANCE Whooping cough is mainly caused by Bordetella pertussis, and current vaccines are targeted against this organism. Recently, there have been increasing outbreaks of whooping cough, even where vaccine coverage is high. Analysis of the genomes of 343 B. pertussis isolates from around the world over the last 100 years suggests that the organism has emerged within the last 500 years, consistent with historical records. We show that global transmission of new strains is very rapid and that the worldwide population of B. pertussis is evolving in response to vaccine introduction, potentially enabling vaccine escape.